CD27− γ9+δ2+ T cells were identified as functionally differentiated effector cells during M. tuberculosis infection [33] suggesting that the CD27 negative γ9+ T cell population generated following CHDMAPP treatment is an appropriate phenotype for treating intracellular bacterial infection. This evidence concerns the gene CD27 and bacterial infectious disease.